|
⚲
|
| Keyboard |
| Aisling Capital Management LP
✚
|
|
|---|---|
| CRD # | 269994 |
| SEC # | 801-106625 |
| CIK # | 0001571076, 0001766721 |
| AUM | 716.4 M (2026-03-27) |
| Employees | 12 (67% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-651-6380 |
| Address | 489 Fifth Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/27/2026) [Brochure] |
|---|
ITEM 5. FEES AND COMPENSATION
A. Detailed information regarding the fees that are charged to the Funds is provided in the
relevant Fund’s Offering Documents. The descriptions herein are general in nature. Aisling
is entitled to a management fee as compensation for its services. Aisling also receives
carried interest, calculated based on 20% of realized gains generated by the Funds, less any
unrealized losses deemed permanent and less expenses allocated to the investments
realized, after investors have earned a preferred return of 8%. Further details about certain
common fees and expenses are set forth below.
B. From the initial closing of the Funds until the earlier of (i) the period ending on the fifth
anniversary of the final closing date of the Funds (subject to two one-year extensions with
the consent of the relevant Fund’s advisory board (the “Advisory Board”)) and (ii) the first
date a successor fund to the relevant Fund accrues management fees, the management fees
paid to Aisling will be 2% per annum of the aggregate capital committed by investors.
Thereafter, the management fee will be 2% per annum of actively invested capital.
Management fees are payable by the relevant Fund to Aisling quarterly in advance. The
relevant Fund GP, in its sole discretion, maintains authority to call capital for management
fees and other expenses or pay such fees and expenses out of such Fund’s current income
and from disposition of investments. Where the Offering Documents calculate
management fees based on the amount of capital commitments or the amount of investment
contributions, the amount of management fees generally will not be reduced based on
reductions in investment value, except where specified by the relevant Offering
Documents. As a general matter, management fees will be payable during term extensions
unless otherwise agreed with investors. Except where the Offering Documents expressly
provide to the contrary, management fees will not be reduced (in whole or in part) in the
case of partial distributions or partial sales of investments.
Certain Offering Documents permit Aisling to waive or agree to reduce its management
fee. Certain waived portions of the management fee are treated by the Offering Documents
as a deemed capital contribution by the relevant Fund GP, which is effectively invested in
the relevant Fund on such Fund GP’s behalf and operates to reduce the amount of capital
such Fund GP would otherwise be required to contribute to the Fund. The limited partners
of a Fund could be required to make a pro rata contribution according to their respective
commitments to fund any contribution that would otherwise be required of Aisling in
connection with any such waiver or reduction and, as a result, the exercise of such waiver
could result in an acceleration (or delay) of investor capital contributions. Waived or
reduced management fees are not subject to management fee offset (as described further
below), and the amount of such waived or reduced fees has the potential to be significant.
Due to waived or reduced management fees by Aisling and/or the timing of receipt of
compensation, it is possible that management fee offsets will be delayed, resulting in a net
additional benefit to Aisling.
C. A description of the other types of fees or expenses the Funds are generally expected to
bear are set forth fully in detail in the Offering Documents. As set forth in each Fund’s
Offering Documents, these fees, costs, expenses, liabilities and obligations relating to the
Fund’s (and its subsidiaries’ and intermediate entities’) activities, investments and business
to the extent not reimbursed by a portfolio company generally include, but are not limited
to: (i) activities with respect to the structuring, organizing, negotiating, consummating,
financing, refinancing, acquiring, bidding on, owning, managing, monitoring, operating,
holding, hedging, restructuring, trading, taking public or private, selling, valuing, winding
up, liquidating, or otherwise disposing of, as applicable, the Fund’s portfolio companies
and its actual and potential investments (including follow-on investments) or seeking to do
any of the foregoing (including any associated legal, financing, commitment, transaction
or other fees and expenses payable to attorneys, accountants, investment bankers, lenders,
third-party diligence software and service providers, consultants and similar professionals
in connection therewith and any fees and expenses related to transactions that may have
been offered to co-investors to the extent not borne by co-investors), whether or not any
contemplated transaction or project is consummated and whether or not such activities are
successful; (ii) indebtedness of, or guarantees made by, the Fund, the relevant Fund GP or
any “affiliated partner” on behalf of the Fund (including any credit facility, letter of credit
or similar credit support), including interest with respect thereto, or seeking to put in place
any such indebtedness or guarantee; (iii) financing, commitment, origination and similar
fees and expenses; (iv) broker, dealer, finder, underwriting (including both commissions
and discounts), loan administration, private placement fees, sales commissions, investment
banker, finder and similar services; (v) brokerage, sale, custodial, depository, trustee,
record keeping, account and similar services; (vi) legal, accounting, research, auditing,
administration (including fees and expenses associated with the Fund’s third-party
administrator and administration or reporting software, if any), information, appraisal,
advisory, valuation (including third-party valuations, appraisals or pricing services),
... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/27/2026) [Brochure] |
|---|
ITEM 7. TYPES OF CLIENTS
As further described in Item 4 of this Brochure, Aisling provides investment advisory
services to pooled investment vehicles that are exempt from registration as an investment
company pursuant to Section 3(c)(7) of the Investment Company Act. Interests in the
Funds are limited to individuals and entities that meet the criteria of “qualified purchasers”
as defined in Section 2(a)(51)(A) under the Investment Company Act. The investors
participating in the Funds generally include, but are not limited to, individuals, banks or
thrift institutions, other investment entities, university endowments, sovereign wealth
funds, family offices, pension and profit-sharing plans, trusts, estates or charitable
organizations or other corporations or business entities and from time to time include,
directly or indirectly, principals or other employees of Aisling and its affiliates and
members of their families, Operating Partners or other service providers retained by
Aisling, as well as executives of portfolio companies.
Prospective investors should refer to the applicable Offering Documents for complete
information on the minimum investment requirements for participation in a Fund. Aisling
generally requires a minimum capital commitment of $5 million, although the Fund GP
maintains discretion to individually waive, increase or reduce the minimum investment
required.
Aisling does not currently manage individual investment accounts but may to the extent
Aisling believes, in its discretion, that it is appropriate to do so, offer co-investment
opportunities to Fund investors and/or to third parties. Aisling allocates co-investment
opportunities in the manner described in “Item 8,” below. Except as approved by the
Advisory Board or expressly permitted by the relevant Fund’s Offering Documents, the
relevant Fund GP, the Firm, the senior managers and their respective affiliates shall not, in
their individual capacities, invest in any transaction in which a Fund has made an
investment, other than through the relevant Fund GP or as an investor of the relevant Fund. |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Bridgebio Pharma Inc | 378.0 | ||
| Syndax Pharmaceuticals Inc | 30.8 | ||
| Monte Rosa Therapeutics Inc | 25.6 | ||
| Bicara Therapeutics Inc | 11.3 | ||
| Helix Acquisition Corp II | 9.1 | ||
| Compass Pathways PLC | 7.9 | ||
| Scholar Rock Holding Corp | 3.8 | ||
| Biomea Fusion Inc | 3.1 | ||
| Eupraxia Pharmaceuticals Inc | 2.4 | ||
| UroGen Pharma Ltd | 1.9 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Aisling Capital V LP | [2020-03-30] | 144.2 M | 210.0 M |
| Filed 2020-06-25 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $123,000 · Revenue Decline to Disclose | ||||
| PE | Aisling Capital IV LP | [2015-08-31] | 143.1 M | 506.4 M |
| Offered $400,000,000 · Filed 2016-07-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining $256,900,000 · Duration One year or less · Commission $5,470,000 · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 716.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 716.4 |
| By Discretionary | ||
| Discretionary | 2 | 716.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 716.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 716.4 | |
| Total | 2 | 716.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Steven Elms | Executive Officer | 40 | 2 | |
| Andrew Schiff | Executive Officer | 16 | 2 | |
| Aisling Capital Partners V LP | Executive Officer | 1 | 1 | |
| Aisling Capital Partners IV LLC | Executive Officer | 1 | 1 | |
| Aisling Capital Partners IV LP | Executive Officer | 1 | 1 | |
| Aisling Capital Partners V LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001571076] | |
| 13F-HR | [0001766721] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Pike Street Capital LP
✚
|
WA | 727.4 M |
|
TRGP Investment Partners LP
✚
|
CT | 726.8 M |
|
Haddington Ventures LLC
✚
|
TX | 726.4 M |
|
Union Capital Associates LP
✚
|
CT | 721.5 M |
|
Brydon Group LLC
✚
|
DC | 721.5 M |
|
ParkerGale LLC
✚
|
IL | 719.1 M |
|
Grant Avenue Capital LLC
✚
|
NY | 716.1 M |
|
Bench Walk Advisors LLC
✚
|
FL | 707.6 M |
|
Lincoln Peak Capital Management LLC
✚
|
MA | 706.5 M |
|
Latticework Capital Management LLC
✚
|
TX | 705.1 M |